Clinical and pharmacokinetic effects of combined warfarin and 5-fluorouracil in advanced colon cancer

Cancer Research

Volumn 42, Issue 11, 1982, Pages 4827-4830

  Chan, Kenneth K ^c   Weiner, John M ^b   Bateman, Joseph R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; WARFARIN;

ADVERSE DRUG REACTION; ANIMAL EXPERIMENT; BLOOD; BLOOD AND HEMOPOIETIC SYSTEM; CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COLON CARCINOMA; DIGESTIVE SYSTEM; DRUG BLOOD LEVEL; DRUG INTERACTION; DRUG THERAPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LARGE INTESTINE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; THERAPY;

ADENOCARCINOMA; ANIMALS; COLONIC NEOPLASMS; DRUG THERAPY, COMBINATION; FLUOROURACIL; HUMANS; KINETICS; RABBITS; WARFARIN;

EID: 0020446896     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Agostino, D., Clifton, E., and Giromami. A. Effects of prolonged coumadin treatment on the production of pulmonary métastasés in the rat. Cancer (Phila.), 19: 284–291, 1966.
2. Boulds, B., Dujoune, C., and Azarnoff, D. Warfarin treatment of transplanted fibrosarcoma. Pharmacologist, 13: 260–268, 1971.
3. Brown, J. M. A study of the mechanism by which anticoagulation with warfarin inhibits blood-borne métastasés. Cancer Res., 33: 1217-1224, 1973.
4. Chan, K., Chlebowski, R., Gota, C., and Bateman, J. Pharmacokinetic analysis of the interaction of sodium warfarin with 5-fluorouracil. Clin. Res., 19: 100, 1978.
5. Chlebowski. R. T., Block, J., and Dietrich, M. Warfarin and vitamin K, enhance methotrexate and 5-fluorouracil effects in L1210 cells. Clin. Res., 29:40, 1981.
6. Chlebowski, R. T., Gota, C., Chan, K., Weiner, J., Block, J., and Bateman, J. R. Anticoagulation and 5-fluorouracil (5-FU) in advanced colon cancer: clinical and pharmacokinetic analysis. Proc. Am. Assoc. Cancer Res., 21: 670, 1980.
7. Chlebowski, R. T., Silverberg, I., Pajak, T., Weiner, J. M., Kardinal, C., and Bateman, J. R. Treatment of advanced colon cancer with 5-fluorouracil vs. cyclophosphamide plus 5-fluorouracil: prognostic aspects of the differential white blood count. Cancer (Phila.), 45: 2240-2244, 1980.
8. Cohen, J. L. and Brennan, P. B. A gas chromatographic determination of 5- fluorouracil in biological fluids. J. Pharm. Sci., 62: 573-578, 1973.
9. Diggs, C. H., Wiernick, P. H., and Smyth, A. C. Methyl-CCNU and Ftorafor with or without methanol extracted residue of BCG for metastatic adenocar cinoma of the colon. Cancer Treat. Rep., 67:1581-1583, 1977.
10. D'Souza, D. P., Daly, L., and Thornes, R. D. Levamisole, BCG and warfarin as adjuvants to chemotherapy for increased survival in advanced breast cancer. J. Ir. Med. Assoc., 71: 605-608, 1978.
11. Gehan, E. A. A generalized Wilcoxon test for comparing arbitrarily singly-sensored samples. Biometrika, 52: 203-223, 1965.
12. Kaplan, E. L., and Meier, P. Non-parametric estimation from incomplete observation. J. Am. Stat. Assoc., 53: 457-482. 1958.
13. Kirsch, W. M., Schulz, D., Buskirk, J. J., and Young, H. E. Effects of sodium warfarin and other carcinostatic agents in malignant cells: a study in drug synergy. J. Med. (Basel), 5: 69-75, 1974.
14. Lokich, J. J., Skavin, A. T., Mayer, J., and Frei, E. Lack of effectiveness of combined 5-fluorouracil and methyl-CCNU therapy in advanced colorectal cancer. Cancer (Phila.), 40: 2792-2796, 1977.
15. Moertel, C. G. Current concepts in cancer. Chemotherapy of gastrointestinal cancer. N. Engl. J. Med., 299: 1049-1052, 1978.
16. Myers. C. E. The pharmacology of the fluoropyrimidines. Pharm. Exp. Ther., 33: 1-15, 1981.
17. O'Connel, M. J., Moertel, C. G., Rubin, J., Schutt, A. J., and Creagan, E. T. Lack of clinical synergism between cyclophosphamide. Adriamycin, and c/s-dichlorodiamineplatinum(ll) in metastatic human colorectal carcinoma. Cancer Treat. Rep., 64: 411-413, 1980.
18. Ryan, J., Ketcham, A., and Wexler, H. Reduced incidence of spontaneous métastasés with long term coumadin treatment. Ann. Surg., 168:163-169, 1968.
19. Thornes, R. Anticoagulant therapy in patients with cancer. J. Irish Med. Assoc., 62. 426-431. 1969.
20. Wadell, W. R. Chemotherapy for cancer of the pancreas. Surgery (St. Louis), 74: 420-424, 1973.
21. Wood, S., Jr. Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber. Arch. Pathol., 66: 550-568, 1958.
22. Zacharski, L. R., Henderson, W. G., Rickies. F. R., Forman. W. B., Cornell, C. J., Forcier, R. J., Harrower, H. W., and Johnson. R. D. Rationale and experimental design for the VA cooperative study of anticoagulation (warfarin) in the treatment of cancer. Cancer (Phila.), 44: 732-741, 1979.
23. Zacharski. L. R., Henderson, W. R., Rickies, F. R., Forman, W. B., Cornell, C. J., Forcier, R. J., Harrower, H. W., and Johnson, R. D. Effects of warfarin on survival in small cell carcinoma of the lung. J. Am. Med. Assoc., 245: 831-835. 1981.